Ischemic tolerance is a powerful cerebroprotective mechanism by which a sublethal injury protects from a subsequent lethal ischemic insult. Studies over the last funding period have revealed that the inducible or """"""""immunological"""""""" isoform of nitric oxide synthase (iNOS;NOS II) is essential for the development of the ischemic tolerance induced by systemic administration of the proinflammatory mediator lipopolysaccharide. However, the mechanisms by which iNOS participates in ischemic preconditioning have not been defined. Preconditioning induces cellular and molecular changes that are thought to ultimately increase the resistance of brain pells to ischemia. However, preservation of brain tissue depends not only on protection of neurons and glia, but also on safeguarding cerebral blood vessels. Therefore, it is conceivable that both """"""""cytoprotective"""""""" and """"""""vasoprotective"""""""" mechanisms contribute to the development of ischemic tolerance. The goal of this renewal application is to test the hypothesis that INOS-derived NO contributes to ischemic tolerance by preserving post-ischemic vascular function (vasoprotection). as well as increasing the resistance of brain cells to ischemia (cvtoprotection). First, we will determine whether preconditioning with lipopolysaccharide leads to better preservation of cerebral perfusion after middle cerebral artery occlusion in mice (vasoprotection). Second, we will test the hypothesis that iNOS-derived NO is responsible for the vasoprotective component of preconditioning. Third, we will use a model of NMDA-mediated neocortical injury to test the hypothesis that iNOS is also involved in the tolerance to excitotoxicity induced by lipopolysaccharide (cytoprotection). Fourth, considering that NO exerts many of its actions through peroxynitrite, its reaction product with superoxide, we will test the hypothesis that reactive oxygen species produced by NADPH oxidase are needed for the cytoprotective and vasoprotective effects of iNOS-derived NO. The proposed studies will provide insight into poorly understood aspects of the mechanisms of ischemic preconditioning that may have important implications for the prevention and treatment of ischemic stroke.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS034179-14
Application #
7537231
Study Section
Special Emphasis Panel (ZRG1-BINP-L (01))
Program Officer
Jacobs, Tom P
Project Start
1995-03-20
Project End
2011-11-30
Budget Start
2008-12-01
Budget End
2009-11-30
Support Year
14
Fiscal Year
2009
Total Cost
$367,500
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Neurology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Kahl, Anja; Blanco, Ismary; Jackman, Katherine et al. (2018) Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases. Sci Rep 8:2701
Garcia-Bonilla, Lidia; Brea, David; Benakis, Corinne et al. (2018) Endogenous Protection from Ischemic Brain Injury by Preconditioned Monocytes. J Neurosci 38:6722-6736
Brea, David; Poon, Carrie; Murphy, Michelle et al. (2018) Ablation of nasal-associated lymphoid tissue does not affect focal ischemic brain injury in mice. PLoS One 13:e0205470
Merkler, Alexander E; Diaz, Ivan; Wu, Xian et al. (2018) Duration of Heightened Ischemic Stroke Risk After Acute Myocardial Infarction. J Am Heart Assoc 7:e010782
Anderson, Corey J; Kahl, Anja; Qian, Liping et al. (2018) Prohibitin is a positive modulator of mitochondrial function in PC12 cells under oxidative stress. J Neurochem 146:235-250
Navi, Babak B; Howard, George; Howard, Virginia J et al. (2018) New diagnosis of cancer and the risk of subsequent cerebrovascular events. Neurology 90:e2025-e2033
Merkler, Alexander E; Gialdini, Gino; Lerario, Michael P et al. (2018) Population-Based Assessment of the Long-Term Risk of Seizures in Survivors of Stroke. Stroke 49:1319-1324
Kahl, Anja; Stepanova, Anna; Konrad, Csaba et al. (2018) Critical Role of Flavin and Glutathione in Complex I-Mediated Bioenergetic Failure in Brain Ischemia/Reperfusion Injury. Stroke 49:1223-1231
Burstein, Suzanne R; Kim, Hyun Jeong; Fels, Jasmine A et al. (2018) Estrogen receptor beta modulates permeability transition in brain mitochondria. Biochim Biophys Acta Bioenerg 1859:423-433
Kahl, Anja; Anderson, Corey J; Qian, Liping et al. (2018) Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia. J Cereb Blood Flow Metab 38:1010-1020

Showing the most recent 10 out of 108 publications